US · TRNS · INDUSTRIAL - DISTRIBUTION
Transcat, Inc. (TRNS) intrinsic value and stock valuation
$92.97as of 2026-11-21 · Mkt cap 871.49M
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Transcat, Inc. DCF and intrinsic value
InvestorsCraft values TRNS with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from TRNS’s statements →
Transcat, Inc. Graham Number
Graham Number: $20.44d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2012–2026, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Graham Corporation (GHM) $69.94
- Genco Shipping & Trading Limited (GNK) $22.50
- Quanex Building Products Corporation (NX) $17.62
- Kornit Digital Ltd. (KRNT) $14.60
- Hyster-Yale Materials Handling, Inc. (HY) $16.08
- Kimball Electronics, Inc. (KE) $17.92
- Sturm, Ruger & Company, Inc. (RGR) $51.66
- FTAI Infrastructure Inc. (FIP) $3.31
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $331.9M | $278.4M | $259.5M | $230.6M | $205M |
| Operating income | $13.3M | $17.9M | $19.8M | $16.3M | $14.1M |
| Net income | $5.38M | $14.5M | $13.7M | $10.7M | $11.4M |
| EPSd | $576.6K | $1.57M | $1.63M | $1.4M | $1.5M |
| Operating cash flow | $34.9M | $39M | $32.6M | $17M | $17.6M |
| Capital expenditure | -$-15.3M | -$-13.2M | -$-13.28M | -$-9.41M | -$-10.15M |
| Free cash flow | $19.6M | $25.8M | $19.3M | $7.54M | $7.47M |
| Total assets | $480.5M | $385.2M | $287.6M | $195.8M | $177.8M |
| Total debt | $128.9M | $57.7M | $21.5M | $64.4M | $57.7M |
| Net debt | $123.9M | $56.2M | $1.89M | $62.9M | $56.3M |
| Total equity | $300.6M | $286.9M | $225.2M | $99.6M | $86.2M |
| Cash and short-term investments | $4.94M | $1.52M | $35.2M | $1.53M | $1.4M |
Income statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $331.9M | $278.4M | $259.5M | $230.6M | $205M |
| Cost of revenue | $223.6M | $189M | $175.7M | $162.2M | $146.5M |
| Gross profit | $108.3M | $89.5M | $83.8M | $68.4M | $58.4M |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $95M | $71.6M | $64M | $52.1M | $44.3M |
| Other expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating expenses | $95M | $71.6M | $64M | $52.1M | $44.3M |
| Cost and expenses | $318.6M | $260.6M | $239.7M | $214.3M | $190.8M |
| Interest income | $0.00 | $820K | $810K | $0.00 | $0.00 |
| Interest expense | $5.27M | $800K | $1.83M | $2.42M | $810K |
| Depreciation and amortization | $26.2M | $18.6M | $13.5M | $11M | $9.57M |
| Ebitda | $38.8M | $37.7M | $33.8M | $26.9M | $23.6M |
| Operating income | $13.3M | $17.9M | $19.8M | $16.3M | $14.1M |
| Total other income/expenses, net | -$-5.27M | $450K | -$-1.34M | -$-2.76M | -$-950K |
| Income before tax | $7.99M | $18.3M | $18.4M | $13.5M | $13.2M |
| Income tax expense | $2.61M | $3.81M | $4.79M | $2.8M | $1.81M |
| Net income | $5.38M | $14.5M | $13.7M | $10.7M | $11.4M |
| Weighted average shares outstanding | $9.33M | $9.19M | $8.24M | $7.55M | $7.5M |
| Weighted average diluted shares outstanding | $9.33M | $9.25M | $8.35M | $7.64M | $7.59M |
Balance sheet
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $4.94M | $1.52M | $35.2M | $1.53M | $1.4M |
| Net receivables | $65.8M | $56.3M | $48.3M | $45.2M | $40.3M |
| Inventory | $13.7M | $14.5M | $17.4M | $16.9M | $12.7M |
| Total current assets | $92.5M | $78M | $105.2M | $67.6M | $59.7M |
| Property, plant and equipment, net | $57.8M | $74.4M | $55.8M | $43.9M | $37.5M |
| Goodwill and intangible assets | $295.9M | $231.7M | $125.6M | $83.2M | $79.8M |
| Long-term investments | $0.00 | $100K | $0.00 | $0.00 | $0.00 |
| Total non-current assets | $388M | $307.2M | $182.4M | $128.2M | $118.1M |
| Total assets | $480.5M | $385.2M | $287.6M | $195.8M | $177.8M |
| Accounts payable | $17.9M | $16.8M | $11.5M | $15.9M | $14.2M |
| Short-term debt | $0.00 | $5.44M | $4.85M | $4.58M | $2.16M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $39.6M | $34M | $33.5M | $28.3M | $27.7M |
| Long-term debt | $128.9M | $52.3M | $16.7M | $59.8M | $55.5M |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $140.2M | $64.3M | $28.9M | $67.8M | $63.9M |
| Capital lease obligations | $29M | $25M | $17.4M | $15.3M | $9.19M |
| Total liabilities | $179.9M | $98.4M | $62.4M | $96.1M | $91.6M |
| Common stock | $4.67M | $4.66M | $4.42M | $3.78M | $3.77M |
| Retained earnings | $97.8M | $92.5M | $80.1M | $69.2M | $58.7M |
| Accumulated other comprehensive income (loss) | -$-920K | -$-1.47M | -$-950K | -$-1.2M | -$-230K |
| Total equity | $300.6M | $286.9M | $225.2M | $99.6M | $86.2M |
| Total investments | $0.00 | $100K | $15.5M | $0.00 | $0.00 |
| Total debt | $128.9M | $57.7M | $21.5M | $64.4M | $57.7M |
| Net debt | $123.9M | $56.2M | $1.89M | $62.9M | $56.3M |
Cash flow statement
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net income | $5.38M | $14.5M | $13.7M | $10.7M | $11.4M |
| Depreciation and amortization | $26.2M | $18.6M | $13.5M | $11M | $9.57M |
| Stock-based compensation | $7.55M | $3.25M | $4.51M | $3.38M | $2.33M |
| Change in working capital | -$-11.9M | $3.21M | $2.05M | -$-8.04M | -$-6.34M |
| Accounts receivable | -$-6.58M | -$-1.29M | $410K | $70K | -$-3.39M |
| Inventory | $840K | $4.39M | $2.32M | -$-3.38M | -$-120K |
| Accounts payable | $960K | $4.94M | -$-5M | $1.6M | $1.9M |
| Net cash provided by operating activities | $34.9M | $39M | $32.6M | $17M | $17.6M |
| Investments in property, plant and equipment | -$-15.3M | -$-13.2M | -$-13.28M | -$-9.41M | -$-10.15M |
| Acquisitions, net | -$-82.53M | -$-87.44M | -$-12.86M | -$-9.11M | -$-29.81M |
| Net cash used for investing activities | -$-97.82M | -$-84M | -$-41.67M | -$-18.51M | -$-39.85M |
| Common stock issued | $840K | $1.87M | $77.3M | $660K | $1.49M |
| Common stock repurchased | -$-470K | -$-3.56M | -$-4.91M | -$-450K | -$-6.68M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | $66.5M | $26.9M | $27.4M | $880K | $23.7M |
| Net change in cash | $3.42M | -$-18.13M | $18.1M | $140K | $840K |
| Cash at end of period | $4.94M | $1.52M | $19.7M | $1.53M | $1.4M |
| Operating cash flow | $34.9M | $39M | $32.6M | $17M | $17.6M |
| Capital expenditure | -$-15.3M | -$-13.2M | -$-13.28M | -$-9.41M | -$-10.15M |
| Free cash flow | $19.6M | $25.8M | $19.3M | $7.54M | $7.47M |
Line items
Line items
Line items
About Transcat, Inc.
Transcat, Inc. offers comprehensive calibration and instrument services for laboratories, serving clients across the United States, Canada, and other international markets. The company operates through two distinct divisions: Service and Distribution. The Service division delivers a wide array of offerings, including precision calibration, equipment repair, thorough inspections, analytical qualification, preventive maintenance, and expert consulting. This segment also features its proprietary software, CalTrak, designed to manage documents and assets while streamlining the operational workflow for its calibration centers and customer equipment. Additionally, its "Compliance, Control and Cost" online portal grants customers web-based asset management capabilities and a secure, off-site repository for calibration and other service records. The Distribution division focuses on the sale and rental of instruments for testing, measurement, and control purposes. It also provides valuable supplementary services such as the calibration and certification of newly purchased equipment, equipment leasing, sales of pre-owned machinery, and customized equipment kitting. This division engages customers through its online platform, various digital and print marketing campaigns, proactive outbound sales efforts, and an incoming call center. Transcat primarily caters to highly regulated sectors, particularly the life sciences—encompassing pharmaceutical, biotechnology, medical device, and other FDA-regulated entities. Furthermore, it extends its services and products to aerospace and defense, industrial manufacturing, energy, utilities, and other industries where process accuracy and confirmed equipment performance are paramount. Established in 1964, Transcat, Inc. maintains its corporate headquarters in Rochester, New York.
- CEO
- Jaime A. Irick
- Employees
- 1.41K
- Beta
- 0.68
Explore
Frequently asked questions
What is the intrinsic value of Transcat, Inc. (TRNS)?
Transcat, Inc. (TRNS) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is TRNS undervalued?
TRNS trades at a price of $92.97 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.